Orchestra BioMed Inc. (OBIO)
Orchestra BioMed Statistics
Share Statistics
Orchestra BioMed has 38.31M shares outstanding. The number of shares has increased by 6.22% in one year.
| 38.31M |
| 6.22% |
| 0% |
| 49.81% |
| n/a |
| 297 |
| 0.08% |
Short Selling Information
The latest short interest is 1.19M, so 3.12% of the outstanding shares have been sold short.
| 1.19M |
| 3.12% |
| 6.39% |
| 4.53 |
Valuation Ratios
The PE ratio is -2.41 and the forward PE ratio is -1.84. Orchestra BioMed's PEG ratio is -0.2.
| -2.41 |
| -1.84 |
| 55.83 |
| 2.1 |
| 4.47 |
| -2.9 |
| -0.2 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for Orchestra BioMed.
| n/a |
| n/a |
| n/a |
| n/a |
Financial Position
The company has a current ratio of 4.27, with a Debt / Equity ratio of 0.5.
| 4.27 |
| 4.26 |
| 0.5 |
| -0.26 |
| -0.33 |
| 0 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| n/a |
| n/a |
| n/a |
| $37,685.71 |
| $-871,771.43 |
| 70 |
| 0.03 |
| 1.18 |
Taxes
| n/a |
| 0% |
Stock Price Statistics
The stock price has increased by -61.83% in the last 52 weeks. The beta is 0.63, so Orchestra BioMed's price volatility has been higher than the market average.
| 0.63 |
| -61.83% |
| 2.97 |
| 4.72 |
| 52.98 |
| 382,853 |
Income Statement
In the last 12 months, Orchestra BioMed had revenue of 2.64M and earned -61.02M in profits. Earnings per share was -1.66.
| 2.64M |
| 2.43M |
| -64.3M |
| -61.02M |
| -64.3M |
| -64.3M |
| -1.66 |
Balance Sheet
The company has 22.26M in cash and 16.53M in debt, giving a net cash position of 5.73M.
| 22.26M |
| 16.53M |
| 5.73M |
| -309.88M |
| 59.05M |
| 36.41M |
Cash Flow
In the last 12 months, operating cash flow was -50.56M and capital expenditures -289K, giving a free cash flow of -50.85M.
| -50.56M |
| -289K |
| -50.85M |
| -1.38 |
Margins
Gross margin is 92.27%, with operating and profit margins of -2437.49% and -2313.27%.
| 92.27% |
| -2437.49% |
| -2313.27% |
| -2313.27% |
| -2437.49% |
| -2437.49% |
| -1927.48% |
Dividends & Yields
OBIO does not appear to pay any dividends at this time.
| n/a |
| n/a |
| n/a |
| n/a |
| n/a |
| n/a |
Analyst Forecast
The average price target for OBIO is $12, which is 293.4% higher than the current price. The consensus rating is "Buy".
| $12 |
| 293.4% |
| Buy |
| 5 |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| n/a |
| n/a |
| n/a |
| n/a |
Scores
| -9.31 |
| 3 |